Comparison of the Effects of Three Extract Sorts of Soybean DETAM 1 on the Total Cholesterol Level in Balb-C Male Mice
Abstract
BACKGROUND: Hypercholesterolemia is a major risk factor for coronary heart disease. Pharmacological treatment of hypercholesterolemia are known to have side effects, hence the need for an alternative medicine, like herbal medicine, such as soybean as an example. Research objective is to compare the effects of ethanol extract, protein extract, and ethyl acetate fraction of soybean tempeh Detam-1 on the total serum cholesterol level of male mice.
METHODS: This study was a laboratory experimental study with Completely Randomized Design (CRD) method. Twenty five balb-C strain male mice were allocated into five groups, namely: the negative-control (aquabidest), the positive-control (simvastatin), ethanol extract, protein extract and ethyl acetate fraction of the soybean tempeh Detam-1 and all were fed with high cholesterol containing food for 31 days. Starting on the 18th day all groups were treated for 14 days. The observed parameter was the total serum cholesterol level. The data of the study results were analyzed with ANOVA, followed by Tukey HSD test.
RESULTS: There were significant differences between treatment groups and the negative-control (p=0.004). The reduction of the total cholesterol level of soy ethanol extract was 35.11±15%, the ethyl acetate fraction of soybean tempeh 26.48±17%, and soy protein extract was 15.33±33.1%, and no significant difference was noted in the positive-control group (simvastatin).
CONCLUSION: The ethanol extract of soybean seed, protein extract of soybean seed, and ethyl acetate fraction of soybean tempeh Detam-1 have the same effect as do simvastin, and ethanol extract of soybean seed is the most effective substance for lowering total serum cholesterol in Balb-C male mice.
KEYWORDS: hypericholesterolemia, ethanol extract, protein extract and ethyl acetate fraction, soybean Detam-1
Full Text:
PDFReferences
World Health Organization. WHO World Health Organization Report 2000. Geneva: WHO; 2001, article.
Ardiansyah. Penyakit jantung koroner; 2005 [cited 2011 Jan 6]. Available from: http://www. medicastore.com/.
Knopp RH. Drug treatment of lipid disorder. N Engl J Med. 1999; 341: 498-511, CrossRef.
Menteri Pertanian RI. Surat Keputusan Menteri Pertanian 2008: Lampiran Keputusan Menteri Pertanian Nomor 240/Kpts/SR120/3/2008 Tanggal 6 Maret 2008. Jakarta: Menteri Pertanian RI; 2008.
Hidayat M, Kurnia D, Sujatno M, Sutadipura N, Setiawan. Perbandingan kandungan makronutrisi dan isoflavon dari kedelai detam 1 dan wilis serta potensinya dalam menurunkan berat badan. Bionatura J Biol Phys. 2010; 12: 5-13.
Hidayat M, Kurnia D, Sujatno M, Sutadipura N, Setiawan, Faried A. β-conglycinin content obtained from two soybean varieties using different preparation and extraction methods. Hayati Journal of Bio Sci. 2011; 18: 37-42, CrossRef.
Hidayat M, Sujatno M, Sutadipura N, Setiawan. Effect several soybean (Glycine Max L. Merr) extracts to food intake, body weight and cholecystokinin plasma in rats. J Physiol Indones. 2009; 8: 151-8.
Hermana, Karmini M. The development of tempe technology. In: Agranoff J, editor. The complete handbook of tempe: The unique fermented soyfood of Indonesia. Singapore: American Soybean Association; 1999. p.81-92.
Santoso HB. Pembuatan tempe dan tahu kedelai bahan makanan bergizi tinggi. 10th ed. Jogjakarta: Kanisius; 2003.
Deak NA, Murphy PA, Johnson LA. Characterization of fractionated soy proteins produced by a new simplified procedure. J Amer Oil Chem Soc. 2007; 84: 137-49, CrossRef.
Prawiroharsono S. Prospek dan manfaat isoflavon untuk kesehatan. Jakarta: Direktorat Teknologi Bioindustri Badan Pengkajian dan Penerapan Teknologi; 2010.
Direktorat Gizi Departemen Kesehatan RI. Daftar komposisi bahan makanan: Pemeliharaan hewan coba. Jakarta : Bhratara Karya Aksara; 1981.
Roche Diagnostics. CHOL cholesterol CHOD-PAP. Indianapolis: Roche Diagnostics; 2005.
Bhathena SJ, Ali A, Handenschild C, Latham P, Ranich T. Mohamed AI, et al. Dietary flaxseed meal is more protective than soy protein concentrate against hypertriglyseridemia and steatosis of the liver in a animal model of obesity. J Am Coll Nutr. 2003; 22: 157-6, CrossRef.
Koshy AS, Anila L, Vijayalakshmi NR. Flavonoids from garcinia cambogia lower lipid levels in hypercholesterolemic rats. Food Chem. 2001; 72: 289-94, CrossRef.
Nishi T, Hara H, Tomita F. Soybean beta-conglycinin peptone suppresses food intake and gastric emptying by increasing plasma cholecystokinin levels in rats. J Nutr. 2003; 133: 352-7, PMID.
Nishi T, Hara H, Hira T, Tomita F. Dietary protein peptic hydrolysates stimulate cholecystokinine release via direct sensing by rat intestinal mucosal cells. Exp Biol Med. 2001; 226: 1031-6, PMID.
Xiao CW. Health effects of soy protein and isoflavones in humans. J Nutr. 2008; 138: 1244S-9S, PMID.
Paillasse MR, de Medina P, Amouroux G, Mhamdi L, Poirot M, Silvente-Poirot S. Signaling through cholesterol esterification: a new pathway for the cholecystokinin 2 receptor involved in cell growth and invasion. J Lipid Res. 2009; 50: 2203-11, CrossRef.
Erdman JW. Soy protein and cardiovascular disease: A statement for healthcare professionals from the nutrition committee of the American Heart Association (AHA). Circulation. 2000; 102: 2555-9, CrossRef.
United Soy Board [homepage on the internet]. Soy Lecithin Facts Sheet [cited 2011 jan 8]. Available from: http://www.soyconnection.com/.
DOI: https://doi.org/10.18585/inabj.v4i3.177
Copyright (c) 2012 The Prodia Education and Research Institute
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Indexed by:
The Prodia Education and Research Institute